May 11, 2018 / 4:35 AM / in a year

Swiss stocks - Factors to watch on May 11

ZURICH, May 11 (Reuters) - The Swiss blue-chip SMI was seen opening 0.7 percent higher at 9,047 points on Friday, according to premarket indications by bank Julius Baer .

Here are some of the main factors that may affect Swiss stocks.


French building materials company Saint-Gobain is set to take a large stake in Switzerland’s Sika AG while abandoning its quest for control in a deal to end a nearly four-year-old hostile takeover attempt that had pitted heirs of the Swiss company’s founder against Sika’s board of directors.

Sika shares were seen rising 8 percent in pre-market indicators.

For for click


As U.S. President Donald Trump prepares to deliver a long-anticipated speech on Friday on curbing prescription drug costs, health industry insiders expect little in the way of policies that would hurt the drugmakers he once accused of “getting away with murder.”

Novartis confirmed it had a $1.2 million contract with the firm of Michael Cohen, Trump’s personal lawyer, adding it soon realised it had made a mistake but had not been able to stop payments until the deal ended.


The Swiss food giant’s $7 billion licensing deal for Starbucks’ retail business gives it a much-needed boost in its battle against JAB, the privately owned investment firm stirring up the coffee industry with a string of deals.

For more click


The Swiss drugmaker’s bid to expand use of its immunotherapy Tecentriq to more cancers suffered a blow on Thursday when the world’s biggest maker of oncology drugs announced it had failed a combination trial against colorectal cancer.


The online luxury retailer Yoox Net-A-Porter is on track to be de-listed following the end of a takeover offer launched by Cartier owner Richemont, data from the Italian bourse showed on Wednesday. Yoox reported on Thursday that Richemont’s holding had reached nearly 95 percent of its shares.

For more click


The Swiss drugmaker said on Wednesday it received a letter from the U.S. Food and Drug Administration saying the agency has identified deficiencies that preclude the continuation of the discussion of labeling and post marketing requirements for Methylene Blue MMX.

For more click


Polyphor said on Friday it decided to increase the Upsize Option of its upcoming share offering from 40 million Swiss francs to 55 million, targeting to raise total gross proceeds of up to 165 million francs. It also announced a narrowed price range of 35 francs to 38 francs per share, from 30-40 francs previously.


* VAT Group said on Wednesday that it successfully launched its first bond over 200 million Swiss francs.

* announced details of the preliminary end result of its partial self tender offer, with a total of 4.7 million lastminute shares having been tendered, or more than twice the object of the offer of 15.83 percent of lastminute’s issued share capital.

* Swiss Prime Site said it sold the Weltpost Park residential development in Bern.

Reporting by Zurich newsroom

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below